QURE
uniQure N.V.
NASDAQ · Healthcare · Biotechnology · NL
$44.50
−0.80%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 80.68x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 9.53x
- Price / sales
- 165.32x
- Price / cash flow
- -19.20x
Enterprise value
- Enterprise value
- $2.3B
- EV / sales
- 125.28x
- EV / EBITDA
- -12.92x
- EV / EBIT
- -11.50x
- Market cap
- $3.1B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026